1 terminated, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 1, Unknown 1 |
Follow Toripalimab: new trials by email Literature Review of Toripalimab trials Research Report on Toripalimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status Toripalimab, CRT, SCRT - Toripalimab, Radiation | Phase 3 | Unknown | Zhejiang Cancer Hospital | 174 | 2022-11-01 | 2022-12-30 |
| Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT Radiotherapy plus Toripalimab, Sorafenib - Radiotherapy, Toripalimab | Phase 3 | Terminated | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 36 | 2021-03-02 | 2025-02-26 |
toripalimab (2) · Capecitabine (1) · Fluorouracil (1) · Irinotecan (1) · Oxaliplatin (1) · Radiotherapy (1) · Sorafenib (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Zhejiang Cancer Hospital (1)
China (2)